← All verdicts
Verdict

Deep Undervalued

Every analyzed stock in Deep Undervalued — 1,156 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Deep Undervalued" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 3.1% below its 1-year high (as of 2026-09-16). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 7.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 0.8 (our deep-undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Robust Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +23.6 pts (608 entries, 188 companies, very unlikely to be luck). 57% of entries beat the S&P; 30% beat it by 30 points or more; 25% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +21.9 pts.
+23.6 ptsvs S&P, average
57%beat the S&P
30%up 30+ pts vs S&P
25%down 20+ pts vs S&P
+24.1 ptsvs small caps, 12 mo
−16.1 pts 2023worst year to buy ?
6.0luck check ?
Does the holding period matter?3 mo: +4.9 pts 52% beat6 mo: +9.1 pts 54% beat12 mo: +23.6 pts 57% beat24 mo: +35.1 pts 52% beat3 yr, per yr: +6.5 pts 46% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today522+15.2 pts t 5.1+16.9 pts
Sell-off (S&P ≥10% off high)86+74.7 pts t 3.7+67.9 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing195+23.5 pts t 4.1+3.4 pts
Other64+13.8 pts t 2.0+9.3 pts
Tech hardware & semis54+14.9 pts t 1.1+2.6 pts
Energy51+27.4 pts t 2.0+4.8 pts
Retail & consumer33+33.7 pts t 2.2+21.4 pts
Services33+13.4 pts t 2.1+18.5 pts
Construction28+19.9 pts t 2.0+3.7 pts
Finance & real estate28+4.9 pts t 0.7+3.1 pts

Holds up out of sample? Before 2018: +17.1 pts (n 274, t 5.9). From 2018: +29.0 pts (n 334, t 4.3). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+8 pts+4 pts+16 pts+28 pts+12 pts+2 pts+28 pts+22 pts−2 pts−12 pts+119 pts+18 pts+26 pts−16 pts−0 pts+36 pts
n9245638293651312743672630454650

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

Sort by: A–Z Riskiest Most overvalued Most shorted Buyers' strike Largest
SMPL
Simply Good Foods Co
Deeply undervalued
Consumer Defensive Risk 34 · Moderate
Price$9.84
Model IV$48.96
P/IV0.24
Discount 80% Return to IV: +397.5%
Market implies -13.8%/yr vs model +8.2% · below model
SMTC
SEMTECH CORP
Valuation N/A
Technology Risk 34 · Moderate
Price$167.24
Model IV—
P/IV—
Market implies +46.7%/yr vs model +10.0% · above model
SMTI
Sanara MedTech Inc.
Deeply undervalued
Healthcare Risk 42 · Elevated
Price$34.92
Model IV$68.98
P/IV0.33
Discount 49% Return to IV: +97.5%
Market implies -13.4%/yr vs model +43.8% · below model
SMWB
SIMILARWEB LTD.
Overvalued
Technology Risk 25 · Moderate
Price$8.61
Model IV$7.40
P/IV0.56
Premium +16% Return to IV: -14.0%
Market implies +4.1%/yr vs model +19.7% · below model
SMXT
SolarMax Technology, Inc.
Deeply undervalued
Industrials Risk 45 · Elevated
Price$1.89
Model IV$3.29
P/IV0.17
Discount 43% Return to IV: +74.2%
Market implies -13.9%/yr vs model +26.7% · below model
SNBR
Sleep Number Corp
Valuation N/A
Consumer Cyclical Risk 68 · High
Price$0.13
Model IV—
P/IV—
Market implies -50.0%/yr vs model +2.0% · below model
SND
Smart Sand, Inc.
Deeply undervalued
Basic Materials Risk 35 · Moderate
Price$5.09
Model IV$11.39
P/IV0.38
Discount 55% Return to IV: +123.8%
Market implies -6.0%/yr vs model +8.0% · below model
SNDA
SONIDA SENIOR LIVING, INC.
Deeply undervalued
Healthcare Risk 47 · Elevated
Price$39.52
Model IV$52.09
P/IV0.68
Discount 24% Return to IV: +31.8%
Market implies -8.9%/yr vs model +12.9% · below model
SNEX
StoneX Group Inc.
Deeply undervalued
Financial Services Risk 33 · Moderate
Price$68.53
Model IV$527.79
P/IV0.21
Discount 87% Return to IV: +670.2%
Market implies -25.3%/yr vs model +9.2% · below model
SNOA
Sonoma Pharmaceuticals, Inc.
Deeply undervalued
Healthcare Risk 29 · Moderate
Price$1.31
Model IV$10.91
P/IV0.10
Discount 88% Return to IV: +735.6%
Market implies -48.8%/yr vs model +2.0% · below model
SNWV
SANUWAVE Health, Inc.
Deeply undervalued
Healthcare Risk 46 · Elevated
Price$4.10
Model IV$23.83
P/IV0.69
Discount 83% Return to IV: +481.3%
Market implies -34.8%/yr vs model +40.3% · below model
SNYR
Synergy CHC Corp.
Valuation N/A
Healthcare Risk 63 · High
Price$0.10
Model IV—
P/IV—
Market implies -50.0%/yr vs model +2.0% · below model
SOAR
Volato Group, Inc.
Valuation N/A
Industrials Risk 43 · Elevated
Price$0.22
Model IV—
P/IV—
Market implies -50.0%/yr vs model +1.1% · below model
SOBO
South Bow Corp
Deeply undervalued
Energy Risk 34 · Moderate
Price$35.99
Model IV$55.30
P/IV0.65
Discount 35% Return to IV: +53.7%
Market implies -2.8%/yr vs model +3.0% · below model
SOHU
Sohu.com Ltd
Deeply undervalued
Technology Risk 34 · Moderate
Price$13.68
Model IV$36.30
P/IV0.37
Discount 62% Return to IV: +165.4%
Market implies -18.6%/yr vs model +2.0% · below model
SOJC
SOUTHERN CO
Deeply undervalued
Utilities Risk 35 · Moderate
Price$18.90
Model IV$55.73
P/IV0.42
Discount 66% Return to IV: +194.9%
SOJE
SOUTHERN CO
Deeply undervalued
Utilities Risk 35 · Moderate
Price$16.15
Model IV$37.17
P/IV0.46
Discount 57% Return to IV: +130.2%
SOJF
SOUTHERN CO
Deeply undervalued
Utilities Risk 36 · Moderate
Price$24.41
Model IV$55.73
P/IV0.45
Discount 56% Return to IV: +128.3%
SOMN
SOUTHERN CO
Undervalued
Utilities Risk 29 · Moderate
Price$46.12
Model IV$55.73
P/IV0.35
Discount 17% Return to IV: +20.8%
SON
SONOCO PRODUCTS CO
Deeply undervalued
Basic Materials Risk 36 · Moderate
Price$47.84
Model IV$76.10
P/IV0.64
Discount 37% Return to IV: +59.1%
Market implies -0.5%/yr vs model +6.9% · below model
SPGI
S&P Global Inc.
Deeply undervalued
Technology Risk 31 · Moderate
Price$410.71
Model IV$626.38
P/IV0.68
Discount 34% Return to IV: +52.5%
Market implies +6.2%/yr vs model +15.2% · below model
SPH
SUBURBAN PROPANE PARTNERS LP
Deeply undervalued
Consumer Cyclical Risk 38 · Moderate
Price$17.07
Model IV$37.73
P/IV0.51
Discount 55% Return to IV: +121.0%
Market implies -7.2%/yr vs model +4.3% · below model
SPOK
Spok Holdings, Inc
Deeply undervalued
Communication Services Risk 36 · Moderate
Price$10.65
Model IV$15.73
P/IV0.65
Discount 32% Return to IV: +47.7%
Market implies -4.5%/yr vs model +3.0% · below model
SPT
Sprout Social, Inc.
Deeply undervalued
Technology Risk 39 · Moderate
Price$10.80
Model IV$28.88
P/IV0.26
Discount 63% Return to IV: +167.4%
Market implies -17.4%/yr vs model +24.9% · below model
SREA
SEMPRA
Deeply undervalued
Utilities Risk 30 · Moderate
Price$19.92
Model IV$67.44
P/IV0.32
Discount 70% Return to IV: +238.6%
SRFM
SURF AIR MOBILITY INC.
Deeply undervalued
Industrials Risk 28 · Moderate
Price$0.51
Model IV$3.15
P/IV0.39
Discount 84% Return to IV: +519.3%
Market implies -30.5%/yr vs model +50.0% · below model
SRJN
SPIRE INC
Valuation N/A
Utilities Risk 35 · Moderate
Price$21.80
Model IV—
P/IV—
Limited data — see page
SRXH
SRx Health Solutions, Inc.
Valuation N/A
Consumer Defensive Risk 42 · Elevated
Price$1.59
Model IV—
P/IV—
Market implies +16.5%/yr vs model +15.0% · in line
SSNC
SS&C Technologies Holdings Inc
Deeply undervalued
Technology Risk 32 · Moderate
Price$80.27
Model IV$126.72
P/IV0.53
Discount 37% Return to IV: +57.9%
Market implies +1.5%/yr vs model +8.9% · below model
SSTI
SOUNDTHINKING, INC.
Deeply undervalued
Technology Risk 33 · Moderate
Price$5.61
Model IV$15.73
P/IV0.48
Discount 64% Return to IV: +180.3%
Market implies -18.7%/yr vs model +15.7% · below model
SSTK
Shutterstock, Inc.
Deeply undervalued
Technology Risk 28 · Moderate
Price$5.26
Model IV$24.33
P/IV0.61
Discount 78% Return to IV: +362.5%
Market implies -18.4%/yr vs model +8.8% · below model
STAK
STAK Inc.
Deeply undervalued
Industrials Risk 38 · Moderate
Price$1.14
Model IV$2.54
P/IV0.38
Discount 55% Return to IV: +122.4%
Market implies -22.9%/yr vs model +8.5% · below model
STEM
STEM, INC.
Deeply undervalued
Technology Risk 28 · Moderate
Price$4.72
Model IV$15.61
P/IV0.47
Discount 70% Return to IV: +230.6%
Market implies -18.7%/yr vs model +5.2% · below model
STG
Sunlands Technology Group
Valuation N/A
Consumer Defensive Risk 32 · Moderate
Price$2.96
Model IV—
P/IV—
Market implies -48.8%/yr vs model +2.0% · below model
STIM
Neuronetics, Inc.
Deeply undervalued
Healthcare Risk 35 · Moderate
Price$3.03
Model IV$2.78
P/IV0.55
Premium +9% Return to IV: -8.3%
Market implies +2.5%/yr vs model +28.2% · below model
STRA
Strategic Education, Inc.
Deeply undervalued
Consumer Defensive Risk 30 · Moderate
Price$81.66
Model IV$131.90
P/IV0.58
Discount 38% Return to IV: +61.5%
Market implies -3.1%/yr vs model +4.3% · below model
STRR
Star Equity Holdings, Inc.
Deeply undervalued
Technology Risk 33 · Moderate
Price$10.40
Model IV$90.50
P/IV0.13
Discount 89% Return to IV: +770.2%
Market implies -50.0%/yr vs model +2.0% · below model
STRRP
Star Equity Holdings, Inc.
Deeply undervalued
Technology Risk 26 · Moderate
Price$9.50
Model IV$93.74
P/IV0.11
Discount 90% Return to IV: +886.7%
Market implies -50.0%/yr vs model +2.0% · below model
STRZ
STARZ ENTERTAINMENT CORP /CN/
Deeply undervalued
Communication Services Risk 34 · Moderate
Price$28.26
Model IV$80.51
P/IV0.29
Discount 65% Return to IV: +184.9%
Market implies -17.5%/yr vs model +2.0% · below model
SUNC
SunocoCorp LLC
Deeply undervalued
Energy Risk 36 · Moderate
Price$81.16
Model IV$206.14
P/IV0.32
Discount 61% Return to IV: +154.0%
Market implies -8.3%/yr vs model +4.4% · below model
SUNS
Sunrise Realty Trust, Inc.
Deeply undervalued
Financial Services Risk 28 · Moderate
Price$7.27
Model IV$17.96
P/IV0.50
Discount 60% Return to IV: +147.0%
SURG
SurgePays, Inc.
Valuation N/A
Communication Services Risk 69 · High
Price$0.15
Model IV—
P/IV—
Market implies -50.0%/yr vs model +2.8% · below model
SWAG
Stran & Company, Inc.
Deeply undervalued
Technology Risk 28 · Moderate
Price$1.69
Model IV$16.62
P/IV0.13
Discount 90% Return to IV: +883.4%
Market implies -50.0%/yr vs model +30.8% · below model
SWAGW
Stran & Company, Inc.
Valuation N/A
Technology Risk 62 · High
Price$0.00
Model IV—
P/IV—
Market implies -50.0%/yr vs model +18.8% · below model
SXC
SunCoke Energy, Inc.
Deeply undervalued
Basic Materials Risk 33 · Moderate
Price$10.02
Model IV$22.58
P/IV0.40
Discount 56% Return to IV: +125.4%
Market implies -8.0%/yr vs model +5.7% · below model
SXTP
60 DEGREES PHARMACEUTICALS, INC.
Deeply undervalued
Healthcare Risk 26 · Moderate
Price$0.90
Model IV$3.42
P/IV0.44
Discount 74% Return to IV: +280.6%
Market implies -23.4%/yr vs model +50.0% · below model
SYF
Synchrony Financial
Deeply undervalued
Financial Services Risk 34 · Moderate
Price$75.99
Model IV$373.26
P/IV0.19
Discount 80% Return to IV: +391.2%
Market implies -19.3%/yr vs model +6.9% · below model
SYM
Symbotic Inc.
Deeply undervalued
Industrials Risk 34 · Moderate
Price$42.13
Model IV$146.75
P/IV0.32
Discount 71% Return to IV: +248.3%
Market implies -0.3%/yr vs model +25.0% · below model
SYPR
SYPRIS SOLUTIONS INC
Deeply undervalued
Healthcare Risk 37 · Moderate
Price$1.88
Model IV$6.71
P/IV0.49
Discount 72% Return to IV: +256.7%
Market implies -25.4%/yr vs model +5.3% · below model
SYY
SYSCO CORP
Deeply undervalued
Consumer Defensive Risk 32 · Moderate
Price$83.54
Model IV$122.67
P/IV0.62
Discount 32% Return to IV: +46.8%
Market implies +4.0%/yr vs model +11.2% · below model
TACT
TRANSACT TECHNOLOGIES INC
Deeply undervalued
Technology Risk 24 · Moderate
Price$5.16
Model IV$10.65
P/IV0.42
Discount 52% Return to IV: +106.4%
Market implies -6.4%/yr vs model +8.5% · below model
TALKW
Talkspace, Inc.
Valuation N/A
Healthcare Risk 35 · Moderate
Price$0.00
Model IV—
P/IV—
Market implies -50.0%/yr vs model +15.0% · below model
TALO
TALOS ENERGY INC.
Deeply undervalued
Energy Risk 39 · Moderate
Price$17.68
Model IV$87.37
P/IV0.17
Discount 80% Return to IV: +394.2%
Market implies -14.6%/yr vs model +7.8% · below model
TAP
MOLSON COORS BEVERAGE CO
Deeply undervalued
Consumer Defensive Risk 39 · Moderate
Price$39.27
Model IV$162.14
P/IV0.24
Discount 76% Return to IV: +312.9%
Market implies -12.8%/yr vs model +5.2% · below model
TARS
Tarsus Pharmaceuticals, Inc.
Deeply undervalued
Healthcare Risk 36 · Moderate
Price$79.31
Model IV$116.64
P/IV0.51
Discount 32% Return to IV: +47.1%
Market implies -8.8%/yr vs model +50.0% · below model
TASK
TaskUs, Inc.
Undervalued
Technology Risk 45 · Elevated
Price$8.14
Model IV$10.14
P/IV0.62
Discount 20% Return to IV: +24.5%
Market implies +5.3%/yr vs model +11.8% · below model
TBI
TrueBlue, Inc.
Deeply undervalued
Technology Risk 27 · Moderate
Price$8.75
Model IV$73.24
P/IV0.08
Discount 88% Return to IV: +737.1%
Market implies -45.5%/yr vs model +2.0% · below model
TBLAW
Taboola.com Ltd.
Valuation N/A
Technology Risk 39 · Moderate
Price$0.01
Model IV—
P/IV—
Market implies -50.0%/yr vs model +8.6% · below model
TBPH
Theravance Biopharma, Inc.
Deeply undervalued
Healthcare Risk 28 · Moderate
Price$17.01
Model IV$154.19
P/IV0.10
Discount 89% Return to IV: +806.5%
Market implies -16.8%/yr vs model +19.6% · below model
TCBIO
TEXAS CAPITAL BANCSHARES INC/TX
Deeply undervalued
Financial Services Risk 23 · Moderate
Price$19.71
Model IV$69.26
P/IV0.31
Discount 72% Return to IV: +251.4%